The customer, a global biotechnology company with a total turnover of more than $5bn, manufactures different drug substances (BDS) of highly valuable mABs in batch sizes ranging from 10l to 700l for clinical phases up to commercialised products.
The BDS is frozen at < -85 C (-121°F) and shipped within Europe or on transatlantic routes over periods of max. 200 hours, and then stored, all the while being kept cool with dry ice.
To read more, please download this free white paper.
Thank you.Please check your email to download the white paper.